SEC Form 4 · accession 0001140361-15-045485
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger E. Susi
Officer — CEO, President · Director
Period of report
Dec 23, 2015
Accepted (ET)
Dec 23, 2015 · 3:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 23, 2015 | S | 156,521 | $23.28 | D | 5,800,000 | I | By Roger E. Susi Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1In connection with the secondary offering of shares by certain selling shareholders pursuant to an underwriting agreement (the "Underwriting Agreement") and prospectus supplement, each dated December 18, 2015, the Reporting Person, as a selling shareholder, sold shares in the amounts shown in the above table pursuant to the underwriter exercising its overallotment option in full. The secondary offering to closed on December 23, 2015. This amount represents the $24.25 price to public per share, less the underwriting discount of $0.970 per share.
- F2The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.